Master of Science in Cancer Immunotherapy
Program Description
The MSc in Cancer Immunotherapy at the University of Hertfordshire offers advanced training in the interactions between cancer and the immune system, focusing on therapies like T cell adoptive transfer, monoclonal antibodies, and immune checkpoint inhibition. Students engage in problem-based learning and hands-on laboratory research in state-of-the-art facilities, preparing them for roles in medical R&D, clinical trials, and biopharmaceutical industries. Graduates often join organizations such as Roche, Merck, and AstraZeneca, or pursue further research degrees.
Program Requirements
Language Requirements
| Test | Overall Score | Listening | Reading | Writing | Speaking |
|---|---|---|---|---|---|
| IELTS | 6.5 | 5.5 | 5.5 | 5.5 | 5.5 |
| PTE - A | 59.0 | 59.0 | 59.0 | 59.0 | 59.0 |
| TOEFL | 79.0 | 17.0 | 18.0 | 17.0 | 20.0 |
Academic Scores
| Scale | Minimum Score Required |
|---|---|
| GPA Scale (0-4.00) | 2.60 |
Program Intakes
| September, 2026 |
|---|
| January, 2027 |
| September, 2027 |
Recommended Programs
1 Year
On Campus
January, September
Applied and Pure Science
1 Year
On Campus
January, September
Applied and Pure Science
1 Year
On Campus
January, September
Applied and Pure Science
1 Year
On Campus
January, September
Applied and Pure Science
